Hybrid Polymers for Stable Bioactive Peptide Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Natural polypeptides often exhibit poor pharmacological properties, limiting their effectiveness as bioactive compounds, and existing synthetic mimics face challenges in achieving stable conformations and enhanced binding affinities.
Innovation Solution
Development of hybrid polymers comprising an abiotic oligomer segment and a polypeptide segment, specifically incorporating serine or threonine residues for bonding, which allows for efficient solid-phase synthesis, diverse chemical functionalities, and enhanced stability and bioactivity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If natural polypeptides are used as bioactive compounds, then they can exhibit extraordinary range of bioactivities, but they display poor pharmacological properties
Solution Approach 1:
The patent creates hybrid polymers that combine abiotic oligomer segments (providing stability and resistance to degradation) with polypeptide segments (providing bioactivity). This composite structure allows the material to simultaneously exhibit the desirable bioactivities of natural polypeptides while gaining the pharmacological stability and resistance to proteolytic degradation characteristic of synthetic polymers.
2Adaptability or versatility
If synthetic mimics of peptides are developed, then they can show potential as partial mimics with some structural and functional attributes, but they face challenges in achieving stable conformations and enhanced binding affinities
Solution Approach 1:
The patent divides the polymer structure into distinct segments: abiotic oligomer segments that provide conformational stability through intramolecular interactions, and polypeptide segments that provide the desired structural and functional attributes for binding. This segmentation allows each part to optimize its specific function without compromising the other.
Solution Approach 2:
The patent modifies physical and chemical parameters of the polymer structure, including introducing covalent constraints through macrocyclization and non-covalent intramolecular interactions, to enhance conformational ordering and stability while maintaining the functional attributes needed for binding affinity.
3Reliability
If methods are developed to enhance conformational ordering of non-natural polymers, then binding affinities can be enhanced, but the complexity of synthesis and characterization increases
Solution Approach 1:
The patent incorporates conformational constraints and intramolecular interactions into the polymer design from the outset, during the synthesis stage, rather than attempting to induce them later. This preliminary action simplifies the overall process by building stability and binding affinity into the fundamental structure.
Solution Approach 2:
The patent uses specific chemical groups and intramolecular interactions as intermediaries that facilitate both conformational ordering and binding. These intermediatory structures serve dual purposes: stabilizing the polymer conformation and mediating interactions with target molecules, thereby enhancing binding affinity without proportionally increasing synthesis complexity.
Data Source
AI summary
Novel hybrid polymers are disclosed that have a structure represented by the following formula I:wherein Abiotic oligomer, Polypeptide, X, Y, and R1 are as described herein. The methods to prepare the hybrid polymers via novel oxazolidinyl compounds are also described.